Cellectis S.A. (CMVLF)
OTCMKTS · Delayed Price · Currency is USD
4.400
-0.100 (-2.22%)
At close: Dec 29, 2025
Cellectis Market Cap
Cellectis has a market cap or net worth of $269.89 million as of February 12, 2026. Its market cap has increased by 142.38% in one year.
Market Cap
269.89M
Enterprise Value
306.91M
Revenue
82.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.40
Market Cap Chart
Since February 7, 2007, Cellectis's market cap has increased from 130.96M to 269.89M, an increase of 106.09%. That is a compound annual growth rate of 3.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 269.89M | -24.24% |
| Dec 31, 2025 | 356.23M | 193.37% |
| Dec 31, 2024 | 121.43M | -44.61% |
| Dec 29, 2023 | 219.21M | 126.48% |
| Dec 30, 2022 | 96.79M | -74.85% |
| Dec 31, 2021 | 384.80M | -69.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |